ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
AtriCure, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026
$55.53−0.54 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $2.71B
- P/E (TTM)
- 264.4
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
53M of 51M shares
Institutional holders
252
53 new, 22 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 17 sales
Net sold $4.37M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 7,837,484 | 15.40% | 13G (passive) amendment | Sep 30, 2026 |
| Wellington Management Group LLP | 3,969,269 | 8.00% | 13G (passive) | Jun 30, 2025 |
| Wellington Investment Advisors Holdings LLP | 3,382,555 | 6.80% | 13G (passive) amendment | Mar 31, 2026 |
| Hood River Capital Management LLC | 3,096,611 | 6.23% | 13G (passive) amendment | Dec 31, 2025 |
| AllianceBernstein L.P. | 2,768,365 | 5.50% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Portfolio Management | 2,744,685 | 5.51% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 2,532,965 | 5.08% | 13G (passive) | Mar 31, 2026 |
| Macquarie Management Holdings Inc | 2,503,205 | 5.06% | 13G (passive) | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ATRC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,474,548 | 8.80% | $125.20M | +431,867 | 0.00% |
| Wellington Management Group Llp | 3,495,603 | 6.87% | $97.81M | +113,048 | 0.02% |
| Vanguard Portfolio Management LLC | 3,127,195 | 6.15% | $87.50M | +424,563 | 0.00% |
| Hood River Capital Management LLC | 2,905,299 | 5.71% | $81.29M | −212,246 | 0.59% |
| Alliancebernstein L.P. | 2,768,365 | 5.44% | $78.98M | −490,507 | 0.03% |
| Vanguard Capital Management LLC | 2,190,413 | 4.31% | $61.29M | +34,649 | 0.00% |
| Nomura Asset Management International Inc. | 1,734,279 | 3.41% | $48.53M | −70,648 | 0.07% |
| Goldman Sachs Group Inc | 1,597,988 | 3.14% | $44.71M | −69,178 | 0.00% |
| State Street Corp | 1,389,989 | 2.73% | $38.94M | +87,827 | 0.00% |
| Marshall Wace, Llp | 1,333,904 | 2.62% | $37.32M | −133,620 | 0.03% |
| Geode Capital Management, LLC | 1,319,687 | 2.59% | $36.93M | +93,571 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 1,296,209 | 2.55% | $36.27M | +1,018,527 | 0.02% |
| Dimensional Fund Advisors LP | 1,044,034 | 2.05% | $29.22M | +46,275 | 0.01% |
| GW&K Investment Management, LLC | 949,516 | 1.87% | $26.57K | −13,899 | 0.21% |
| Neuberger Berman Group LLC | 947,982 | 1.86% | $26.58M | −102,300 | 0.02% |
| Champlain Investment Partners, LLC | 938,567 | 1.85% | $26.26M | −32,544 | 0.67% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 897,419 | 1.76% | $25.11M | −163,387 | 0.03% |
| Bank Of America Corp /De/ | 874,370 | 1.72% | $24.46M | +105,809 | 0.00% |
| Kennedy Capital Management LLC | 857,787 | 1.69% | $24.00M | +23,632 | 0.42% |
| Divisadero Street Capital Management, LP | 800,931 | 1.57% | $22.41M | −359,024 | 0.51% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 252 | 53M | 100.0% | 53 / 102 | 61 / 22 | 7M | 5M |
| Q1 2026 | 224 | 50M | 98.3% | 35 / 83 | 66 / 41 | 11M | 5M |
| Q4 2025 | 234 | 49M | 95.9% | 36 / 91 | 74 / 21 | 6M | 6M |
| Q3 2025 | 223 | 48M | 95.1% | 34 / 70 | 82 / 11 | 3M | 4M |
| Q2 2025 | 201 | 49M | 96.3% | 17 / 78 | 72 / 35 | 6M | 7M |
| Q1 2025 | 221 | 50M | 99.1% | 38 / 77 | 64 / 28 | 8M | 3M |
| Q4 2024 | 213 | 47M | 91.5% | 39 / 69 | 73 / 23 | 3M | 6M |
| Q3 2024 | 202 | 50M | 97.6% | 40 / 58 | 79 / 34 | 10M | 6M |
| Q2 2024 | 198 | 51M | 100.0% | 26 / 102 | 52 / 51 | 9M | 9M |
| Q1 2024 | 224 | 52M | 100.0% | 33 / 84 | 81 / 40 | 10M | 6M |
| Q4 2023 | 233 | 48M | 94.4% | 40 / 102 | 70 / 33 | 6M | 3M |
| Q3 2023 | 230 | 45M | 89.2% | 29 / 93 | 79 / 20 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ATRC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Hood River Small-Cap Growth Fund | 1,527,073 | 3.00% | $42.73M | 0.64% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,519,312 | 2.99% | $42.51M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,296,745 | 2.55% | $36.28M | 0.04% | Jun 30, 2026 |
| Nomura Small Cap Core Fund | 1,219,526 | 2.40% | $33.74M | 0.61% | May 29, 2026 |
| Vanguard Small-Cap Index Fund | 1,102,113 | 2.17% | $30.84M | 0.02% | Jun 30, 2026 |
| Ab Discovery Growth Fund, Inc. | 737,624 | 1.45% | $20.64M | 0.71% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 632,851 | 1.24% | $17.71M | 0.04% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 580,489 | 1.14% | $16.24M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 545,392 | 1.07% | $20.59M | 0.06% | Jul 31, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 461,390 | 0.91% | $12.91M | 0.22% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 460,871 | 0.91% | $12.90M | 0.08% | Jun 30, 2026 |
| Champlain Small Company Fund | 383,000 | 0.75% | $10.72M | 1.29% | Jun 30, 2026 |
| Osterweis Opportunity Fund | 353,985 | 0.70% | $9.90M | 2.59% | Jun 30, 2026 |
| MFS New Discovery Fund | 341,866 | 0.67% | $9.46M | 0.44% | May 31, 2026 |
| EQ/AB Small Cap Growth Portfolio | 305,345 | 0.60% | $8.54M | 0.38% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael H. Carrel | President, CEO, & Director | 796,694 | 1.57% | Aug 3, 2026 |
| Salvatore Privitera | Chief Technical Officer | 142,745 | 0.28% | Sep 24, 2026 |
| Karl S. Dahlquist | Chief Legal Officer | 87,319 | 0.17% | Aug 26, 2026 |
| Justin J. Noznesky | Chief Mktg & Strategy Officer | 100,219 | 0.20% | Jul 30, 2026 |
| Vinayak Doraiswamy | Chief Scientific Officer | 86,511 | 0.17% | Jul 30, 2026 |
| Douglas J. Seith | Chief Operating Officer | 229,867 | 0.45% | Jul 2, 2026 |
| Angela L. Wirick | Chief Financial Officer | 204,893 | 0.40% | Mar 3, 2026 |
| Deborah Lee Yount | Chief Human Resources Officer | 57,539 | 0.11% | Mar 4, 2025 |
| Regina E. Groves | Director | 34,546 | 0.07% | Sep 14, 2026 |
| Karen Prange | Director | 22,809 | 0.04% | Aug 7, 2026 |
| Maggie Yuen | Director | 14,015 | 0.03% | Aug 7, 2026 |
| Sven Wehrwein | Director | 40,518 | 0.08% | Jul 30, 2026 |
| Robert S. White | Director | 128,318 | 0.25% | May 20, 2026 |
| Deborah H. Telman | Director | 28,328 | 0.06% | May 20, 2026 |
| B. Kristine Johnson | Director | 55,954 | 0.11% | May 20, 2026 |
| Shlomo Nachman | Director | 24,655 | 0.05% | May 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Salvatore Privitera Chief Technical Officer | Sep 23, 2026 | Sale(10b5-1 plan) | −4,519 | $60.00 | $271.14K | 142,745 |
| Regina E. Groves Director | Sep 11, 2026 | Sale | −5,313 | $54.22 | $288.07K | 34,546 |
| Salvatore Privitera Chief Technical Officer | Sep 8, 2026 | Sale(10b5-1 plan) | −3,657 | $55.00 | $201.14K | 147,264 |
| Salvatore Privitera Chief Technical Officer | Sep 2, 2026 | Sale(10b5-1 plan) | −7,763 | $52.50 | $407.56K | 150,921 |
| Karl S. Dahlquist Chief Legal Officer | Aug 24, 2026 | Sale | −9,370 | $48.89 | $458.10K | 87,319 |
| Maggie Yuen Director | Aug 5, 2026 | Sale | −3,500 | $38.42 | $134.47K | 14,015 |
| Karen Prange Director | Aug 5, 2026 | Sale | −3,564 | $38.80 | $138.28K | 22,809 |
| Michael H. Carrel President, CEO, & Director | Jul 30, 2026 | Gift | −700 | – | – | 778,434 |
| Michael H. Carrel President, CEO, & Director | Jul 30, 2026 | Gift | −4,000 | – | – | 774,434 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Jul 29, 2026 | Sale | −6,182 | $38.80 | $239.86K | 100,219 |
| Vinayak Doraiswamy Chief Scientific Officer | Jul 28, 2026 | Sale | −6,000 | $38.88 | $233.28K | 86,511 |
| Sven Wehrwein Director | Jul 28, 2026 | Sale | −25,000 | $37.84 | $946.00K | 40,518 |
| Sven Wehrwein Director | Jul 28, 2026 | Option exercise | +25,000 | $19.95 | $498.75K | 65,518 |
| Salvatore Privitera Chief Technical Officer | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 158,684 |
| Douglas J. Seith Chief Operating Officer | Jun 30, 2026 | Award | +527 | $23.78 | $12.53K | 229,867 |
| Karl S. Dahlquist Chief Legal Officer | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 96,689 |
| Vinayak Doraiswamy Chief Scientific Officer | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 92,511 |
| Michael H. Carrel President, CEO, & Director | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 779,134 |
| Karen Prange Director | May 20, 2026 | Sale | −3,000 | $28.65 | $85.95K | 26,373 |
| Deborah H. Telman Director | May 18, 2026 | Award | +6,144 | – | – | 28,328 |
| Robert S. White Director | May 18, 2026 | Award | +6,144 | – | – | 128,318 |
| Karen Prange Director | May 18, 2026 | Award | +6,144 | – | – | 29,373 |
| Sven Wehrwein Director | May 18, 2026 | Award | +6,144 | – | – | 40,518 |
| Regina E. Groves Director | May 18, 2026 | Award | +6,144 | – | – | 39,859 |
| Maggie Yuen Director | May 18, 2026 | Award | +6,144 | – | – | 17,515 |
| B. Kristine Johnson Director | May 18, 2026 | Award | +6,144 | – | – | 55,954 |
| Shlomo Nachman Director | May 18, 2026 | Award | +6,144 | – | – | 24,655 |
| Vinayak Doraiswamy Chief Scientific Officer | May 15, 2026 | Sale | −5,000 | $28.13 | $140.65K | 91,875 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 12, 2026 | Sale | −5,000 | $29.83 | $149.15K | 96,875 |
| Robert S. White Director | Mar 10, 2026 | Option exercise | +10,000 | $14.99 | $149.90K | 122,174 |
| Michael H. Carrel President, CEO, & Director | Mar 6, 2026 | Gift | −1,000 | – | – | 778,498 |
| Michael H. Carrel President, CEO, & Director | Mar 6, 2026 | Gift | −5,000 | – | – | 779,498 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Mar 1, 2026 | Tax withholding | −15,586 | $31.26 | $487.22K | 106,401 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Mar 1, 2026 | Award | +27,991 | – | – | 106,789 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Mar 1, 2026 | Award | +15,198 | – | – | 121,987 |
| Angela L. Wirick Chief Financial Officer | Mar 1, 2026 | Tax withholding | −22,965 | $31.26 | $717.89K | 204,893 |
| Angela L. Wirick Chief Financial Officer | Mar 1, 2026 | Award | +23,101 | – | – | 227,858 |
| Angela L. Wirick Chief Financial Officer | Mar 1, 2026 | Award | +39,987 | – | – | 204,757 |
| Douglas J. Seith Chief Operating Officer | Mar 1, 2026 | Tax withholding | −22,948 | $31.26 | $717.35K | 229,340 |
| Douglas J. Seith Chief Operating Officer | Mar 1, 2026 | Award | +42,386 | – | – | 226,756 |
| Douglas J. Seith Chief Operating Officer | Mar 1, 2026 | Award | +25,532 | – | – | 252,288 |
| Karl S. Dahlquist Chief Legal Officer | Mar 1, 2026 | Award | +27,991 | – | – | 96,542 |
| Karl S. Dahlquist Chief Legal Officer | Mar 1, 2026 | Tax withholding | −15,687 | $31.26 | $490.38K | 96,053 |
| Karl S. Dahlquist Chief Legal Officer | Mar 1, 2026 | Award | +15,198 | – | – | 111,740 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 1, 2026 | Tax withholding | −15,585 | $31.26 | $487.19K | 101,875 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 1, 2026 | Award | +15,198 | – | – | 117,460 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 1, 2026 | Award | +30,390 | – | – | 102,262 |
| Michael H. Carrel President, CEO, & Director | Mar 1, 2026 | Tax withholding | −72,777 | $31.26 | $2.28M | 784,498 |
| Michael H. Carrel President, CEO, & Director | Mar 1, 2026 | Award | +101,280 | – | – | 857,275 |
| Michael H. Carrel President, CEO, & Director | Mar 1, 2026 | Award | +68,618 | – | – | 755,995 |
| Salvatore Privitera Chief Technical Officer | Mar 1, 2026 | Award | +30,390 | – | – | 155,977 |
| Salvatore Privitera Chief Technical Officer | Mar 1, 2026 | Award | +15,198 | – | – | 171,175 |
| Salvatore Privitera Chief Technical Officer | Mar 1, 2026 | Tax withholding | −13,127 | $31.26 | $410.35K | 158,048 |
| Douglas J. Seith Chief Operating Officer | Dec 31, 2025 | Award | +257 | $27.37 | $7.03K | 184,370 |
| Michael H. Carrel President, CEO, & Director | Dec 10, 2025 | Gift | −4,000 | – | – | 687,377 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Nov 26, 2025 | Sale | −5,166 | $37.29 | $192.64K | 78,798 |
| Sven Wehrwein Director | Nov 25, 2025 | Sale | −4,967 | $38.00 | $188.75K | 34,374 |
| Sven Wehrwein Director | Nov 25, 2025 | Option exercise | +4,967 | $19.95 | $99.09K | 39,341 |
| Sven Wehrwein Director | Nov 24, 2025 | Sale | −5,033 | $37.32 | $187.83K | 34,374 |
| Sven Wehrwein Director | Nov 24, 2025 | Option exercise | +5,033 | $19.95 | $100.41K | 39,407 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Privitera Salvatore Officer | Sep 23, 2026 | 4,519 | $271.14K | Sep 23, 2026 | Performance Shares |
| Regina E. Groves Director | Sep 11, 2026 | 5,313 | $285.10K | Sep 10, 2026 | Stock Award |
| Privitera Salvatore Officer | Sep 8, 2026 | 3,657 | $201.14K | Sep 8, 2026 | Performance Shares |
| Privitera Salvatore Officer | Sep 2, 2026 | 7,763 | $407.56K | Sep 2, 2026 | Restricted Stock |
| Dahlquist Karl Officer | Aug 24, 2026 | 9,370 | $458.09K | Aug 24, 2026 | Performance Shares |
| Yuen Maggie Director | Aug 5, 2026 | 3,500 | $134.47K | Aug 5, 2026 | Restricted Stock |
| Karen Prange Director | Aug 5, 2026 | 3,564 | $139.00K | Aug 5, 2026 | Stock Award |
| Justin J. Noznesky Officer | Jul 29, 2026 | 6,182 | $239.88K | Jul 29, 2026 | STOCK GRANT |
| Wehrwein Sven Director | Jul 28, 2026 | 25,000 | $964.44K | Jul 28, 2026 | Stock Option Exercise |
| Doraiswamy Vinayak Officer | Jul 28, 2026 | 6,000 | $233.28K | Jul 28, 2026 | Performance Shares |
| Karen Prange Director | May 20, 2026 | 3,000 | $86.40K | May 20, 2026 | Stock Award |
| Doraiswamy Vinayak Officer | May 15, 2026 | 5,000 | $140.67K | May 15, 2026 | Performance Shares |
| Doraiswamy Vinayak Officer | Mar 12, 2026 | 5,000 | $149.15K | Mar 12, 2026 | Performance Shares |
| Justin J. Noznesky Officer | Nov 26, 2025 | 5,166 | $192.64K | Nov 26, 2025 | STOCK GRANT |
| Wehrwein Sven Director | Nov 25, 2025 | 4,967 | $188.75K | Nov 25, 2025 | Stock Option Exercise |